APA (7th ed.) Citation

Märten, A., Büchler, M. W., Werft, W., Wente, M. N., Kirschfink, M., & Schmidt, J. (2010). Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology. Journal of immunotherapy, 33(2), . https://doi.org/10.1097/CJI.0b013e3181bed29f

Chicago Style (17th ed.) Citation

Märten, Angela, Markus W. Büchler, Wiebke Werft, Moritz N. Wente, Michael Kirschfink, and Jan Schmidt. "Soluble IC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and Radiology." Journal of Immunotherapy 33, no. 2 (2010). https://doi.org/10.1097/CJI.0b013e3181bed29f.

MLA (9th ed.) Citation

Märten, Angela, et al. "Soluble IC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and Radiology." Journal of Immunotherapy, vol. 33, no. 2, 2010, https://doi.org/10.1097/CJI.0b013e3181bed29f.